Can B Corp (CANB) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Can B Corp (CANB) has a cash flow conversion efficiency ratio of -0.001x as of September 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($9.10K) by net assets ($-9.79 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Can B Corp (CANB) defensive interval to measure how many days the company can operate on defensive assets alone.
Can B Corp - Cash Flow Conversion Efficiency Trend (2010–2023)
This chart illustrates how Can B Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Can B Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Can B Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Ceylon Graphite Corp
V:CYL
|
1.418x |
|
Literacy Capital PLC
LSE:BOOK
|
-0.008x |
|
Crown LNG Holdings Limited Warrants
NASDAQ:CGBSW
|
-0.192x |
|
Catheter Precision Inc.
NYSE MKT:VTAK
|
-0.227x |
|
Wellnex Life Ltd
AU:WNX
|
0.154x |
|
Falcon Oil & Gas Ltd.
LSE:FOG
|
-0.027x |
|
Webac Holding AG
F:RKB
|
-0.022x |
|
JEMTEC Inc
V:JTC
|
0.025x |
Annual Cash Flow Conversion Efficiency for Can B Corp (2010–2023)
The table below shows the annual cash flow conversion efficiency of Can B Corp from 2010 to 2023. For the full company profile with market capitalisation and key ratios, see CANB company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | $-1.00 Million | $-1.30 Million | 1.302x | +188.98% |
| 2022-12-31 | $2.70 Million | $-3.95 Million | -1.463x | -12.28% |
| 2021-12-31 | $5.62 Million | $-7.32 Million | -1.303x | -117.90% |
| 2020-12-31 | $3.26 Million | $-1.95 Million | -0.598x | -57.75% |
| 2019-12-31 | $6.37 Million | $-2.41 Million | -0.379x | -75.52% |
| 2018-12-31 | $3.49 Million | $-753.57K | -0.216x | -230.51% |
| 2017-12-31 | $-1.73 Million | $-286.29K | 0.165x | -40.21% |
| 2016-12-31 | $-514.59K | $-142.43K | 0.277x | +107.70% |
| 2015-12-31 | $99.99K | $-359.62K | -3.597x | -3813.38% |
| 2014-12-31 | $98.82K | $-9.08K | -0.092x | +98.50% |
| 2013-12-31 | $61.42K | $-375.97K | -6.121x | +61.68% |
| 2012-12-31 | $34.72K | $-554.69K | -15.975x | -4647.76% |
| 2011-12-31 | $1.18 Million | $-396.78K | -0.336x | -139.19% |
| 2010-12-31 | $-174.70K | $-149.99K | 0.859x | -- |
About Can B Corp
Can B Corp. develops, manufactures, and sells hemp biomass derived products containing cannabinoids. The company provides hemp cannabinoid products, including oils, creams, moisturizers, isolate, gel caps, spa products, concentrates, and lifestyle products. It sells its products under the Canbiola and Pure Leaf Oil brands through medical professionals under distribution agreements and its website… Read more